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ABSTRACT
STATEMENT OF THE PROBLEM:
“A STUDY TO DETERMINE  THE EFFECTIVENESS  OF NORMAL
SALINE   MOUTH   WASH   ON   PREVENTION   OF   ORAL   MUCOSITIS
AMONG   PATIENTS   RECEIVING   CHEMOTHERAPY   IN   SELECTED
HOSPITAL, ERODE DISTRICT” 
OBJECTIVES OF THE STUDY:
1. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who receive normal saline mouth wash.
2. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who do not receive normal saline mouth wash
3. To evaluate the effectiveness of normal saline mouth wash by comparing
the  occurrence of oral mucositis among the patients of experimental and
control group.
4. To find out the association between the occurrence of oral mucositis among
patients and their selected demographic variables.
METHODS:
The  research  approach  adopted  for  this  study  was  quantitative
evaluative approach. The research design adopted for this study was Quasi -
experimental  posttests  only  control  group  design.  The  Non-Probability
purposive sampling technique was used in this study.
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MAJOR FINDINGS OF THE STUDY:
 In experimental group after giving normal saline mouth wash. On 10th
day  one  subject  (3.33%)  had  developed  moderate  oral  mucositis,  and
another one subject (3.33%) had developed mild oral mucositis.
 On  10th day,  2  (6.67%)  of  the  samples  had  developed  severe  oral
mucositis,  27  (90%)  of  the  samples  had  developed  moderate  oral
mucositis and one subject (3.3%) had developed mild oral mucositis in
the control group.
 The mean difference between experimental and control group on 7th day
was 1.667, 8 day was 2.1336, 9th day was 2.1 and 10th day was 2.4994.
 Calculated the ‘t’ value on 7th day was 11.80035219 on 8th day t value was
3.78760275, on  9th day t value was 4.526250023, and on 10th day t value
was 25.54773056.
 In  control  group  the  chi-square  value  for  the  occupation  χ2=20.750,
frequency  of brushing  χ2=11.737,  stages  of  cancer  χ2=30.646,
chemotherapy χ2=15.124, and duration of illness χ2=17.716.
In experimental  group the chi  square value of the frequency of mouth
wash  χ2=19.551, stages of cancer  χ2=23.772, chemotherapy  χ2 =19.362,
and duration of illness χ2 =19.812.
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CONCLUSION:
“A perfect stitch makes a perfect body”. The research findings of the
present study have proved that the normal saline mouth wash is effective in
preventing the client from the occurrence of oral mucositis among those who
are receiving chemotherapy. Thus it is getting from the verb that, "prevention
is better than cure". the nurse who is taking care of a client can prevent their
clients from oral mucositis thus preserves the client self image and gives way
to the client to be esteemed one.
15
CHAPTER-I
INTRODUCTION
“Prevention is better than cure”
WHO  is  supporting  the  international  union  against  cancer  and
pronounced World Cancer Day on 4th February 2010 to promote ways to ease
the global burden of cancer. Preventing cancer and raising quality of life for
cancer patients are recurring themes.
The  theme  of  this  year  on  world  cancer  day  is  “cancer  can  be
prevented too”.  Brown,  (2007),  conducted a study on commonly observed
oral complications after chemotherapy. He revealed that, oral mucositis is seen
within first two weeks of chemotherapy to the head and neck cancer and is
related  to  the  dose  and  duration  of  treatment.  Early  signs  included dryness
progressing to irritative hypermia and oedema with mucosa appearing red and
swollen. He concluded that the purpose of oral care in cancer patients is to
prevent further damage to oral mucosa and reduce oral complication.
Abnormal  growth  of  cells  which  have  an  ability  to  invade  adjacent
tissues  and  even  distant  organs,  which  leads  to  the  eventual  death  of  the
affected patient, if the turnover has progressed beyond that stage when it can
be removed successfully.  Cancer can occur at any site (or) tissue of the body
and may involve any type of cells.
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Maddireddy, (2009), explained that, the term oral mucositis emerged in
the  late  1980's  to  describe  the  adverse  effects  of  chemotherapy  induced
inflammation of oral mucosa. Symptoms of mucositis may vary from pain and
discomfort to an inability to tolerate food (or) fluid. The oral changes start with
a reddening inside the mouth was observed at the end of first  week of the
treatment.
Amber, (2008), stated that, chemotheraphy is the use of one (or) more
several drugs to kill cancer cells. The anti cancer drugs work by stopping the
division and reproduction of cancer cells.
Marimuthu,  (2007)  conducted  a  study  on  prevention  of  cancer
incidence  in  five  cities-Bangalore,  Chennai,  Delhi,  Bhopal  and  Bombay in
which  he  noticed  that,  there  was  an  increase  in  cancer  mortality  of  about
26.6% than the previously recorded cases in Delhi within a span of 8 years.
There was 50% cancer mortality reported in the age group of 55 years and
above.
Umamaheswari, (2007),  recommended that, prevention measures play
a major role in the treatment of side effects  due to cancer therapy. Patient
should be referred to a dentist for a comprehensive examination to identify and
correct  any  potential  complication  before  cancer  therapy  is  initiated.  Most
importantly patients are instructed to brush their teeth with soft tooth brush and
fluoridated solution after every meal and before bed time. Patients should be
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counselled to rinse mouth thoroughly after every meal. So, that food particle
do not remain in mouth.
Elliot, (2006),  recommended that, patient should brush their teeth 3-4
times a day with a soft tooth brush, patient should rinse their mouth frequently
with  salt  water,  baking  soda  (or)  chlorhexidine  following  chemotherapy,
Unless intra oral (or) interstitial treatment is used. Most patients will develop
soreness, erythema and moderate tanning of epithelium in the treatment period.
Jessica, (2005), normally the rate at which an organ grow and when it
should stop growing is  under the control  of body itself.  The abnormal and
uncontrolled division of  cells  causes cancer which invades and destroy the
surrounding  tissues.  Cancer  is  often  thought  of  an  untreatable,  unbearably
painful  disease  with  no  cure.  However,  popular  views  of  cancer  may  be
exaggerated and over generalized.
Nurse is a vital person in identifying and educating the patients who are
at risk for developing chemotherapy (or) radiation therapy induced mucositis.
Prompt identification and initiation of treatment will help the patient to control
the mucositis and to improve the prognosis. So nursing care should include the
oral hygiene assessment and management with normal saline mouth wash.
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NEED FOR THE STUDY
Cancer  statistics  of  India  (2009),  described  that,  every  year  about
85,000 new cancer cases are diagnosed. In that, about 58,000 cancer related
death occur every year. India has the highest number of oral and throat cancer
in the world with the median age at diagnosis is about 60 years and the average
life span is about 58 years in India compared to 75 in developed world.
Oral  and  gastro  intestinal  (GI)  mucositis  can  affect  upto  100%  of
patients  undergoing  high  dose  chemotherapy  and  hematopoietic  stem  cell
transplantation (HSCT). 80% of patients with malignancies of the head and
neck  receiving  radiotherapy  and  a  wide  range  of  patients  receiving
chemotherapy. Alimentary tract mucositis  increases mortality and morbidity
and contributes to rising health care costs. However, with 5-fluorourail (5-FU)
up to 40% get mucositis and 10-15% get oral mucositis with the grade of 3-4.
75-85%  of  bone  marrow  transplantation  recipients  experiences
mucositis  among  which  oral  mucositis  is  the  most  common  and  most
debilitating, especially when melphalan is used. In grade 3 oral mucositis, the
patient is unable to eat solid  food, and in grade 4 the patients are unable to
consume liquids as well. (Wikipedia)
Daffler,  (2007),  explained  that,  within  5-7  days  histologic  changes
occur, 7-14 days visible inflammation and ulceration and for 21 days there is
resolution of mucositis. He recommended four steps to improve prognosis are
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regular dental evaluation, patient education for intensive oral hygiene, daily
oral assessment, symptomatic treatment and prevention of complications.
Maheswar,  (2007)  reported  that,  ulcerative  oral  mucositis  occurs  in
approximately  40%  of  patients  receiving  chemotherapy.  In  approximately,
50%  of  these  patients,  the  lesions  were  severe  and  required  medical
intervention  including  modification  of  their  cytotoxic  chemotherapy.  The
degree and duration of mucositis in patients treated with radiation therapy were
related to radiation source, dose, dose intensity, volume of radiated mucosa,
smoking, alcohol consumption and oral hygiene.
Hubbard, (2006), identified, several drugs associated with propensity to
damage oral mucosa, there include metheotrexate, doxorubicine, 5 fluroruracil,
buscilfan,  bleomycin  and  platinum  co-ordination  complexes.  A  variety  of
patient related factors are responsible for increased potential for developing
mucositis after chemotherapy and radiation therapy. It is stated that, up to 75%
of  the  general  population  had  chronic  periodonatal  disease.  It  is  also
hypothesized  that,  many  acute  bacterial  super  infectious  may  follow
chemotherapy. Patients with improved oral hygiene can abstains from smoking
can definitely reduce the incidence and severity of mucositis.
WHO (2004),  cancer  is  a  leading  cause  of  death  worldwide  which
accounted for 7.4 million deaths around 13% of all deaths in 2004. The main
types of cancer leading to overall cancer mortality each year are:
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• Lung (1.3 million deaths / year)
• Stomach (803000 deaths)
• Colorectal (63900 deaths)
• Liver (610000 deaths)
• Breast (519000 deaths)
More than 70% of all cancer deaths occurred in low-and middle income
countries. Deaths from cancer worldwide are projected to continue rising with
an estimated 12 million deaths in 2030.
The most frequent types of cancer worldwide (in order the number of
global deaths) are,
Among  men  -  Lung,  stomach,  liver,  colorectal,  oesophagus  and
prostate.
• Among women - Breast, lung, stomach, colorectal, and cervical.
Beck, (2004)  during the investigator's  clinical experience she noticed,
patients who have postponed their treatment for the reason of mucositis and
immune suppression which otherwise won't occur if they maintains regular oral
hygiene practice and good nutrition. So, the researcher intended to do a study
on effectiveness of normal saline gargle and oral hygiene practice in preventing
mucositis.
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STATEMENT OF THE PROBLEM:
"A  STUDY  TO  DETERMINE  THE  EFFECTIVENESS  OF
NORMAL  SALINE  MOUTH  WASH  ON  PREVENTION  OF  ORAL
MUCOSITIS AMONG PATIENTS RECEIVING CHEMOTHERAPY IN
SELECTED HOSPITAL, ERODE DISTRICT”
OBJECTIVES OF THE STUDY
1. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who receive normal saline mouth wash.
2. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who do not receive normal saline mouth wash
3. To evaluate the effectiveness of normal saline mouth wash by comparing
the occurrence of oral mucositis among the patients of experimental group
and control group.
4. To find out the association between the occurrence of oral mucositis among
patients and their selected demographic variables.
HYPOTHESIS
The following hypotheses are formulated for the study.
H1 - There will be significant reduction in the occurrence of oral mucositis for
those receiving normal saline mouth wash.
 Patient receiving chemotherapy will develop mucositis from 4-5 days of
treatment.
 Normal saline mouth wash will have a therapeutic effect in preventing    
chemotherapy induced oral mucositis.
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OPERATIONAL DEFINITION
• Chemotherapy  - refers to the use of cytotoxic drugs to treat patients
diagnosed with cancer.
• Oral mucositis  - refers to the soreness and erythema of oral mucosa
occurring as a side effect of chemotherapy which can be assessed using
WHO mucositis assessment scale and patient judged mucositis grading
scale developed by
(DENISE.J.MAHOOD)
• Normal saline mouth wash – rinsing the oral cavity with 0.9% sodium
chloride solution at room temperature.
• Effectiveness - Reduction in the occurrence of oral mucositis as assessed
by using WHO scale for assessing oral mucositis and patient judged oral
mucositis grading scale after the administration of saline mouth wash.
• Prevention  - The management of those factors that could lead to oral
mucositis so as to prevent the occurrence of the oral mucositis.
LIMITATIONS
 The study is limited to those who are receiving chemotherapy.
 The study is limited to 2 weeks period only.
 To those who are willing to participate.
 Limited to only those patients who are receiving chemotherapy during
the data collection period.
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CONCEPTUAL FRAME WORK
Roy's Adaptation Model -1999 (Modified)
Conceptualization is the process of forming ideas designs and plan .A
conceptual frame works deals with the concepts assembled together by their
relevance  to  research  problems,  which  provides  a  certain  framework  of
reference for clinical practice, research and education.
-   Polit and Hungler, 1999
The  conceptual  framework  used  in  this  study  was  based  on  Sister
Calista  Roy's  Adaptation  models  (1999),  which  views the  individual  as  an
adaptive  system,  who  functions  as  a  whole,  through  the  interdependent  of
subjects.
Input:
Input consists of stimuli which can come from the environment (or)
within a person. In this study stimulus from the external environmental are
occupation,  frequency  of  mouth  wash,  brushing,  personal  habits
chemotherapy drugs, chemotherapy, types of cancer and the internal factors
which  contributes  within  the  patients  are  age,  sex,  stages  of  cancer  and
duration of illness.
Throughput:
Throughput  makes  person  processors  and  effectors,  processors  refer
control mechanism that a person uses an adaptive system.
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Physiologic needs:
In involves body basic needs. Here the physiologic need of the client is
to prevent the oral mucosal damage which encounters oral mucositis and to
maintain normal mucosal integrity.
Self concept:
It refers to the perception of oneself in maintaining a good body image. 
Here it refers to the clients belief in prevention of oral mucositis on his own.
Interdependent:
Interdependent   refers   to   interact   with   health   team   members   to 
seek information about care of oral mucosa.
Role function:
In this the role function of the clients is to follow the advices given by
the health team members and maintaining oral hygiene as adviced by the health
team members.
Output:
In this, the experimental groups who received oral saline mouth wash by
following the advices given shown an adaptive behaviours by means of healthy
and intact oral mucosa. Whereas, in control group who have not been received
oral  saline  mouth  wash  exhibited  a  maladaptive  behavioural  by  means  of
impaired oral integrity.
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Fig.1: Conceptual frame work based on Roy’s adaptation model –
1999 (Modified)
26
CHAPTER II
REVIEW OF LITERATURE
The  term  "review  of  literature"  refers  to  the  activities  involved  in
identifying  and  searching  for  information  on  a  topic  and  developing  a
comprehensive picture of the state of knowledge on that topic.
- Polit and Hungler, 2008
Thus the review of literature is an essential step in the development of a
research  project.  It  helps  the  researcher  to  design  the  proposed  study  in  a
scientific manner to achieve the desired result. It helps to determine the gaps,
consistencies and inconsistencies in the available literature about a particular
subject under the study.
The collected literature have been divided into the following sections,
Section A: Literature related to cancer and its treatment.
Section  B:  Literature  related  to  the  side  effects  of  cancer  therapy  and
management.
Section  C:  Literature  related  to  oral  complications  and  management  with
saline gargle.
Section A: CANCER AND ITS TREATMENT
Cancer  Society  of  India,  (2009)  identified,  cancer  as  the  second
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leading cause of death worldwide and was expected to increase by 50% in the
coming 25 years. Two third of new cases are detected in the advanced staged
when the treatment is ineffective. Such patients continue to block and exhaust
the resources which otherwise could effectively be utilized for the treatment of
patient in early stage.
National Cancer Institute, (2008)  described that,  a cancer incidence
rate is the number of new cancers of a specific site occurring in a specified
population during a year usually expressed as number of cancers per 1,00,000
population. Cancer incidence rate in India is 85,000 per year.
Tumey, (2007)  described that, among females, the most common site
for cancers were breast and cervical cancer. In older population based cancer
registries, Barshi and Chennai, PBCR had always recorded highest incidence
of cervical cancer. The highest age specific incidence rate of 98.2 per 100,000
for cancer was seen in 60-64 years age group, which for breast cancer (87.4)
was seen in 45-55 age groups. Based on data of PBCR the estimated number of
new cancers during 2008 in India was 90,708.
Robert,  (2007),  conducted  a  study  on  lung  cancer  due  to  smoking
which revealed the incidence that lung cancer accounts for more than 50 % of
all male death from cancer in western countries. Where, it is widely prevalent
of  all  deaths  from  lung  cancer,  small  cell  carcinoma  accounts  for  25%,
sequemous for 50%, large cell 10% and adenocarcenoma 10%. A tumor arising
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from a peripheral  bronchus may attain  a  very large size without  producing
significant degree of collapse. In small cell type cancer, radiation can be used
only over some parts of the body, where cancer has spread and is for treating
the symptoms not for cure.
American  Cancer  Society,  (2006),  Cancer  is  a  feared  and  dreaded
disease for several reasons. It may be present in an advanced stage with no
symptoms,  compliance  with  vigorous  treatment  and  sometimes  disfiguring.
Treatment does not guarantee a cure.
Galen, (2006), described the cancer as crab like nature. Cancer may be
regarded as a group of diseases characterized by an abnormal growth of cells.
Which has an ability to invade adjacent tissues and distant organs ends with an
eventual death, if the tumor has progressed beyond that stage, when it cannot
be successfully removed.
Mc Cathy, (2006) described that, presently more than 50% oral cancer
are detected only after they have reached an advanced stage such cancer are
disfiguring and painful. The treatment required is both extensive and expensive
and survival rates are low with 5 years. Surgery and radiotherapy can cure only
the early cancer.
Chalette et.al., (2005), performed a study to evaluate the efficiency of
doxorubicin  based  combination  chemotherapy  for  adult  patients  with
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metastatic  soft  tissue  sarcoma.  This  study  stated  that,  survival  rate  tumour
shrinkage is better combination chemotherapy regimens than the single agent
doxorubicin chemotherapy.
Hassey, (2005) stated that, chemotherapy has been widely used for the
palliative management of cancer symptoms. Local control and survival rate is
also high and aiming for caring the illness. The established methods of treating
cancers are chemotherapy, radiation therapy, surgery, and hormonal treatment.
In some cases, multiple techniques are used in sequence to treat cancer.
Siegel,  (2005)  conducted  a  study  about  the  role  of  adjuvant
chemotherapy in metastasis of breast cancer and found that; the patients were
achieved months (or) years of symptom free survival.
Farniok and Levitt, (2004), showed that, the important role played by
chemotherapy  in  the  treatment  of  patients  with  colorectal  cancer.  Ceratin
randomized trials showed that, patients with colon cancer treated with surgery
and radiation had better control  rates (93% and 72%) compared to patients
treated  with  surgery alone.  In  addition,  patients  with  tumor  have improved
local control when they received post operative chemotherapy.
Pollack et.al. (2004), conducted a study among 835 patients to find the
relationship of increasing chemotherapy drug dose to reduce distant metastases
and mortality in men with prostate cancer.  With a median follow up of 64
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months,  there were significant reduction in rates of chemical failure distant
metastasis and overall mortality in patients with prostate cancer and this study
showed  the  effectiveness  of  ugh  dose  chemotherapy  in  controlling  distant
metastasis.
Section    B:    THE    SIDE    EFFECTS    OF    CANCER    THERAPY
AND MANAGEMENT:
Paul,  (2008)  conducted  an  awareness  programme  for  reducing
chemotherapy induced mucositis in Kerala. The programme provided scientific
information of self care, exercise and nurses support to promote prevention of
mucositis.  The effectiveness of this programme was tested on a large scale
randomized control trial. The result had shown a reduction in incidence of oral
mucositis from 46% to 26%.
Algemir et.al., (2007)  analyzed the side effect of 938 cancer patient's
prior  to  the  treatment  and  found  that  patients  anticipated  an  average  of  7
symptoms and the most common expected side effects were fatigue, nausea,
mucositis, abdominal pain, dry mouth, hair loss and skin problem.
Clare,  (2007),  performed  a  study  to  investigate  the  side  effects
experienced  by  patients  with  colorectal  cancer  receiving  5-flurouracil
chemotherapy. This study revealed that, oral mucositis as the worst side effect
experienced by the patients and also change in taste and weight loss.
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Dodd,  (2007),  In  California,  conducted  a  study  among  48  cancer
patients with varying diagnosis who were receiving chemotherapy to assess the
self  care behaviors for the side effects of chemotherapy. The common side
effects were nausea, vomiting, mouth blisters,  alopecia,  constipation,  the  self
care behaviors  for nausea and vomiting was taking prescribed medicine, for
mouth blisters avoiding certain type of food items and use of topical solutions,
for constipation increase roughage in diet; wearing a wig (or) hat were most
frequently reported behaviors for hair loss.
Evan,  (2007)  stated  that,  teaching  the  patients  about  adequate  oral
intake  before  and  after  during  cisplatin-therapy  and  maintaining  accurate
intake and output record during therapy can prevent the renal cell damage due
to  cisplatin  administration.  She  suggested  that,  a  proper  evaluation  of
electrolyte  level  and  renal  functioning  also  could  aid  in  preventing  the
complication.
Emerton, and Philip, (2007), conducted a study on quality of life and
oral functions in patients treated  with radiation  therapy and chemotherapy to
assess the quality of life. Oral function and oral symptoms in cohorts of patient
during and after radiation therapy and chemotherapy which  concluded that,
oral complication during and  after radiation therapy and chemotherapy were
common and affect the quality of life.
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Quargnenti, (2007) performed a study by using a risk assessment tool
for  evaluating  the  side  effects  among  30  patients  after  their  first  cycle  of
chemotherapy. The most common side effects reported by the patients were
anaemia (45%), oral mucosal problems (30%), nausea and vomiting (20%) and
constipation (15%).
Rubenstein, (2007) conducted a study among 35 patients ranked three
most burdensome side effects that interfered with homework school and social
relationship. The patients rated burdensome side effect are 17(49%) reported
mucositis, 15(43%) reported diarrhoea and 3(10%) reported constipation.
Judith, (2006) conducted, "a study on the effect of mucositis on quality
of life in patients with head and neck cancer". In that large retrospective review
of stage III and IV head and neck cancer patients who have been undergoing
chemotherapy  and  reditation  therapy  among  were  83%  developed  oral
mucositis.
Winterberg,  (2006) conducted  a  descriptive  study among 19 cancer
patients  receiving  chemotherapy  with  cyclophosphamide,  doxorubicin,
vincristine, predrisolone and to assess problem experience by the patient's and
found that all the patients experienced alopecia and mucositis (79%) the other
problems were fatigue (72%) taste changes (77%) and constipation (60%).
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Section  C:  ORAL  COMPLICATIONS  AND  MANAGEMENT  WITH
SALINE GARGLE:
World health organization (2009), developed an oral toxicity scale for
the measurement of oral mucositis which include 5 grades beginning from 0 to
4 the grade o is none category, grade 1 is soreness and discomfort, grade 2 is
erythematic  ulcer, grade 3 is extensive ulcer and grade 4 is alimentation not
possible.
Epstein, (2008) stated that, nasopharyngeal mucositis is a common and
treatment limiting side effect of cancer therapy. Severe oral mucositis can lead
to  the  need  to  interrupt  (or)  discontinue  cancer  therapy  and  this  may  also
increase the risk of local and systemic infection and significantly affect the
quality of life and cost of care.
Madankumar  (2008),  done  a  comparative  study  to  assess  the
effectiveness  of  saline  soda  and  providone  iodine  on  76  patients.  Results
showed, there is no difference in efficiency between the two solutions. The
study demonstrated the use of alcohol free solution could reduce the severity
and delay the onset of oral mucositis due to anti neoplasitc radiotherapy. Thus
improving the quality of life for patients, the use of alcohol free solutions could
be advocated for the patients.
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Silverman, (2008)  explained that, patients have mucositis, there were
three to ten days following chemotherapy patients may experience a burning
sensation followed by ulcers. When ulceration develops, treatment is mostly
supportive until the cells regenerate themselves, which takes about 7-14 days.
Marylin, (2008) stated that, mucositis is a general term referring to an
inflammatory reaction and ulcerative lesions of the mouth and oropharynx that
occur secondary to  radiation therapy and certain chemotherapy agents.  The
tissue  destruction  and  functional  alteration  in  the  oral  cavity  become  an
inevitable  problem  when  the  patients  with  cancer  receive  the  treatment
especially radiation therapy. Mucosal lining of the oral cavity, oropharynx and
oesophagus are sensitive to radiation therapy.
Brown,  (2007),  conducted  a  study  on  commonly  observed  oral
complications  after  chemotherapy.  He revealed  that,  oral  mucositis  is  seen
within first two weeks of radiation therapy to the head and neck cancer and is
related to the dose and duration of  treatment.  Early signs included dryness
progressing to irritative hypermia and oedema with mucosa appearing red and
swollen. He concluded that the purpose of oral care in cancer patients is to
prevent further damage to oral mucosa and reduce oral complication.
Sonis,  (2007),  Oncology  nurses  have  developed  scoring  systems  for
assessment of oral mucositis and for patient management. Oral mucosa rating
scale  had  examination  rating  scale  to  quantify  the  type  and  severity  of
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clinically evident oral mucosal changes like atrophy, erythema, ulceration and
pseudomembranous hyperkeratotic lichenoid and oedematous changes with a
scale ranging from 0 to 3.
Johnson, (2006)  suggested that, pre-treatment eradication of infection
and maintenance of good oral hygiene have been the main stay of therapeutic
options  for  patient's  with  radiation  therapy  and  chemotherapy  induced
mucositis . A healthy oral and gastrointestinal mucosa is of significant value of
emotional  expression,  verbal  communication,  comfort,  nutrition,  elimination
and fluid and electrolyte imbalance.
Ching, (2006) conducted a prospective comparative study to determine
the  effect  of  oral  care  protocol  intervention in  prevention  of  chemotherapy
induced oral mucositis in cancer patients 21 children who were included in the
first four month period of study were constituted as control group and another
21 children who were enrolled in subsequent four months were assigned to the
experimental group, which they were given an oral protocol intervention. The
oral care protocol consisted to tooth brushing, 0.2% chlorhexidne mouth rinses
and 0.9% saline rinses. Children in both groups were evaluated twice a week
for three weeks. The results were severity of oral mucositis and related pain
were significantly reduced with intervention in the ratio of 3:2.
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CHAPTER III
METHODOLOGY
Research methodology is the systematic way of doing research to solve a
problem. It comprises of the statement of the problem, the objectives of the
study, the hypothesis that have been formulated, the variables under study, the
methods used for data collection and the statistical methods used for analyzing
the data and the logic behind it. (Kothari, 2003).
On the whole it gives a general pattern of gathering and processing the
Research data.
This chapter deals with the research approach, research design, setting,
population,  sample,  sampling  technique,  criteria  for  sample  selection,
development and description of the tool, validity, reliability, pilot study and the
data collection procedures.
RESEARCH APPROACH:     
It is an applied form of research that involves finding out how well a
program, practice, procedure (or) policies are working.
(Polit, 2004)
The choice of research approach constitutes one of the major decision,
which must be made in conducting research study.
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The  research  approach  adopted  for  the  study  was  quantitative
(Evaluative) approach.
RESEARCH DESIGN:
Polit (2004) stated that, researcher’s overall plan for obtaining answers
to the research questions or for testing the research hypothesis referred to the
research design.
The research design adopted for the study was Quasi Experimental – Post test  only
control group design.
Group Samplingtechnique Pre test Treatment Post test
Experimental
group
- Normal
saline  mouth
wash is given
O1-  Observed  the
degree  of  mucositis
by  WHO  oral
mucositis
assessment scale.
Control
group
- O1-  Observed  the
degree  of  mucositis
by  WHO  oral
mucositis
assessment scale.
Experimental
group
- X1 O1
Control group - - O1
X1 - Intervention
O1- Post test.
VARIABLES UNDER STUDY:
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Treece and Treece (1988)  stated that, a variables is anything that can
change (or) anything that is liable to vary.
Independent Variable:
Treece  and  Treece  (1988)  Stated  that,  independent  variables  is  the
variables that stands alone and is not dependent on any other. It is the cause of
the action.
In this   study,   the   independent variable   is normal   saline mouth
wash administrated to those who are receiving chemotherapy.
Dependent variables:
Treece and Treece (1988),  stated that,  the dependent variables is the
effect of the action of the independent variable and cannot exist by it.
In this,  study dependent  variables is  the lever of mucositis  of cancer
patients those who are receiving chemotherapy.
Extraneous variables:
Age,  sex,  occupation,  chemotherapy drugs,  stage of  cancer,  personal
habits, types of cancer.
POPULATION:
Polit  and  Hungler  (2004)  stated  that,  population  is  an  entire
aggregation of cases that a designed set criteria.
The population for this study is all  the cancer patients those who are
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receiving chemotherapy.
SAMPLE:
Polit and Hungler (2004), Stated that, a sample consists of a subset of
the units that compose the population.
The samples for this study included all cancer patients those who are
receiving  chemotherapy  at  Erode  Cancer  Centre  Hospital,  Thindal,  Erode
District, who fulfills the inclusion criteria.
SAMPLE SIZE:
Total sample is 60.
¾ Experimental group:
30  samples  have  been  grouped  as  experimental  group  who  received
normal mouth wash.
¾ Control group:
30 samples have been grouped as control group, who have not received
normal saline mouth wash.
SAMPLING TECHNIQUE:
Polit  and  Hungler  (2004)  stated  that,  sampling  is  the  process  of
selecting a portion of population to obtain data regarding a problem.
In this study non-probability sampling technique was used to select the
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sample by using purposive samples (or) sampling method.
SITE OF THE STUDY:
The site of this study was Erode Cancer Center, Thindal, Erode District. 
SETTING OF THE STUDY:
The setting of  this  study was General  ward at  Erode Cancer  Center,
Thindal, Erode District.
CRITERIA FOR SELECTION OF SAMPLE:
Inclusion criteria: 
¾ Patients without oral cancer
¾ Patients who are willing to participate in this study.
¾ Patients who are able to follow instruction.
Exclusion criteria:
¾ Patients who have already have extensive severe mucositis.
¾ Patients who are receiving chemotherapy for more than 4 days.
¾ Patients with the habits of tobacco chewing.
SELECTION AND DEVELOPMENT OF INSTRUMENT:
Polit and Hungler (2004)  stated that, the data collection tools are the
procedure (or) instruments used by the researcher to observe (or) measure the
key variables in the research problem.
Selection for Instrument:
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The    investigator  utilized    "standardized  modified    WHO   oral
mucositis Assessment scale".
Development of the tool:
The following steps have been carried to develop the research tool,
1. Related literatures have been reviewed.
2. Blue print was prepared.
3. Consultations of the subject experts were taken and alteration was made
accordingly.
4. Consultation with statistician was done for the preparation of the plan
for statistical data analysis.
5. The literatures include journals, articles, books, published and research
studies were reviewed and used for the development of tool.
DESCRIPTION OF THE DATA COLLECTION INSTRUMENT:
The  instrument  used  for  data  collection  was  "standardized  modified
WHO oral mucositis assessment scale". 
PART I: Demographic variables:
The  selected  demographic  variables  of  the  study  are  life  age,  sex,
occupation,  chemotherapy  drugs,    and  frequency  of  mouthwash,  brushing,
duration of illness, chemotherapy, stages of cancer, personal habits, and types
of cancer.
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PART II: WHO, oral mucositis assessment scale:
WHO, oral mucositis assessment scale to assess the grade o£ mucositis
in patients receiving chemotherapy after thoroughly inspecting their oral cavity
on the 10th day of this chemotherapy cycle.
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
None
Soreness
+
Erythema
Erythema,
Ulcer, can eat
solid food
Ulcers with
extensive
erythema,
liquid diet
only
No possible
alimentation.
For analysis the score 0-4 was given to no mucositis, mild, moderate
and severe mucositis possible respectively.
Grading criteria:
Grade WHO oral mucositis assessment scale Inference
Grade - 0 None
Mild mucositisGrade - 1 Soreness + Erythema
Grade - 2 Erythema, Ulcer, can eat solid food
Moderate mucositisGrade - 3 Ulcers with extensive erythema, liquid diet 
only
Grade-4 No possible alimentation Severe
0 - 1 Mild, 2-3 Moderate, 4 - Severe
VALIDITY AND RELIABILITY:
Validity:
Polit  and  Hungler,  (2004)  stated  that,  content  validity  refers  to  the
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degree to which an instrument measures what it is suppose to measure.
To establish content validity. Tool was given to 5 experts in the field of
the nursing, (medical surgical nursing) and oncology (oncologist).
According to the   experts opinion   some   change have been made   in
demographic data and the tool was finalized.
Reliability of the tool:
Reliability is defined as the extent to which the instrument yields the
same results on expected measure; it is concerned with consistency, accuracy,
stability and homogeneity.
In this study "standardized WHO oral mucositis assessment scale" was
used to measure the mucositis level of patients.
PILOT STUDY:
The purpose of conducting the pilot study was to find out the feasibility
and practicability of the study. 6 patients were selected in the HCG and the
pilot study was conducted for 2 weeks.
The investigator had obtained written permission from the administrator
of  HCG  Hospital  prior  to  the  pilot  study.  The  purpose  of  the  study  was
explained to each subject and an informed consent was obtained prior to the
study, confidentiality was assured to all subjects.
Assignment  of  the  samples  (3  each)  was  done  to  experimental  and
control group. Experimental group received normal saline mouth wash from
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the investigator. Both groups had regular care from the health professionals
such  as  doctors  and  nurses.  A  concise  data  analysis  was  done  by  using
descriptive and inferential statistics.
The  tools  were  found to  be  feasible,  practicable,  and  acceptable  and
there was no necessity to make any further changes after the pilot study.
DATA COLLECTION PROCEDURE:
1. Formal administrative permission was obtained to conduct the study. It
was obtained from the chief medical officer, General ward in charge of
Erode Cancer Center, Erode.
2. The  investigator  had  contact  with  all  the  subjects  in  the  study
individually, and the nature of the help, cooperation required and the
purpose of the study were explained to them.
3. Confidentiality  was  assured  to  all  subjects  and  obtained  informed
consent from the subjects indicating the willingness to participate in the
study. Samples were selected as per the sampling criteria and divided
into two groups.
4. The  investigator  ensured  that,  the  data  collection  process  would  not
affect the routine of the ward.
5. Experimental  group  received  normal  saline  mouth  wash  from  the
investigator while control group do not receive it, but both groups had
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the support and care from the health professionals as per routine.
6. The  degree  of  the  oral  mucositis  was  assessed  with  the  WHO  oral
mucositis  assessment  scale  in  each  phase,  (0,  1,  2,  3,  4)  among
experimental and control group of chemotherapy receiving clients.
7. Data collection was terminated after thanking each of the subjects.
PLAN FOR DATA ANALYSIS:
Polit and Hungler (2004), stated that, the data analysis is the systematic
organization  and  synthesis  of  research  data  and  the  testing  of  research
hypothesis using those data.
The  analysis  plan  is  based  on  the  objectives  of  the  study  using
descriptive and inferential statistics after organizing the data in master coding
sheet.
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Plan for data analysis:
S.
No.
Data Analysis Method Remarks
1. Descriptive
statistics
Mean,  standard
deviation,  mean
percentage.
Assess the degree of mucositis
in  experimental  and  control
group.
2. Inferential
statistics
Unpaired ‘t’ test Compare  the  mucositis  level
by  experimental  and  control
group.
Chi-Square test Association  between  oral
mucositis  and  selected
demographic  variables  of
experimental  and  control
group.
ETHICAL CLEARANCE:
¾ The  study  was  conducted  after  the  approval  from  the  Head  of  the
Institute,  Dharmaratnakara  Dr.  Mahalingam  Institute  of  Paramedical
Science and Research.
¾ Permission was obtained from the chief medical officer of Erode Cancer
Center Hospital, Thindal, Erode District.
¾ The  study  was  conducted  after  getting  consent  from  the  study
participants 
47
SCHEMAIC REPRESENTATION OF THE STUDY DESIGN
Fig. 2 : Schematic representation of the study design
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POPULATION
All cancer patients coming to Erode Cancer Centre 
Hospital, Erode
STUDY SUBJECTS
(Receiving chemotherapy fulfils the inclusive criteria)
SAMPLING TECHNIQUE
(Non-Probability / purposive sampling)
Experimental Group
(N = 30)
Control Group 
 (N = 30)
Normal Saline mouth wash
given by investigator
Normal Saline mouth wash
given by investigator
Assess the degree of mucositis by using WHO oral mucositis
assessment scale. (0, 1, 2, 3, 4)
Data was analysis to find out the level of statistical
significance
CHAPTER-IV
ANALYSIS AND INTERPRETATION
Young  and  Marie  (1996)  stated  that,  the  goal  of  analysis  is  to
summarize the data, so that it might provide answers to the research question.
Analysis of the data involves the translation of information collected during the
course of research project into interpretable, convenient and descriptive terms
to draw inferences known by using statistical method.
STATISTICAL ANALYSIS:
This  chapter  deals  with  the  analysis  and  interpretation  of  the  data
obtained from 60 patients admitted to Erode Cancer Center, Thindal at Erode
District using WHO, oral mucositis assessment scale. The data was processed
and analyzed based on the objectives formulated for the study.
OBJECTIVES OF THE STUDY:
1. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who receive normal saline mouth wash.
2. To  assess  the  degree  of  occurrence  of  oral  mucositis  among  patients
receiving chemotherapy who do not receive normal saline mouth wash.
3. To evaluate the effectiveness of normal saline mouth wash by comparing
the occurrence of oral mucositis among the patients of experimental group
and control group.
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4. To findout the association between the occurrence of oral mucositis among
patients and their selected demographic variables.
DESCRIPTION OF DATA ANALYSIS:
The  data  obtained  was  analyzed  using  descriptive  and  inferential
statistics and presented under the following headings:
Section- 1: Description  of  study  subjects  by  socio  -  demographic
characteristics.
Section - II:   a. Day - by - day scores of oral mucositis of control group.
b. Day  -  by  -  day  scores  of  oral  mucositis  of  experimental
group.
c.  Grading  of  oral  mucositis  on the  10   day  among control
group.
d. Grading of oral mucositis on the 10 day among experimental
group
Section - III: Day  -  by  -  day  comparison  of  grading  of  oral  mucositis
between control group and experimental group.
Section - IV: a) Association between grading of oral mucositis on 10   day of
control group and demographic variables.
b) Association between grading of oral mucositis on 10   day of
experimental group and demographic variables.
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SECTION - I
Table 1: Description of study subjects by socio-demographic
characteristics
N = 60
S.
No. Demographic Variables
Group
Experimental Group Control Group
F % F %
1 Age (in years)
a) 18-29 6 20% 6 20%
b) 30-41 9 30% 8 26.6%
c) 42-53 11 36.6% 11 36.6%
d) 54-65 4 13.3% 5 16.6%
2 Sex
a) Male 11 36.6% 9 30%
b) Female 19 63.3% 21 70%
3 Occupation
a) Cooly 17 56.66% 18 60%
b) Business man 3 10% 3 10%
c) Private employee 5 16.6% 5 16.6%
d) Govt. employee 5 16.6% 4 13.3%
4 Frequency of mouth wash
a) Once a day 2 6.66% 7 23.3%
b) Twice a day 4 13.3% 9 30%
c) Every time after eating 24 80% 14 46.6%
d) Any specific - - - -
5 Frequency of Brushing
a) Once a day 9 30% 24 80%
b) Twice a day 17 56.66% 6 20%
c) Every time after eating 4 13.3% - -
d) Any specific - - - -
S.
No. Demographic Variables
Group
Experimental Group Control Group
F % F %
6 Personal habits
a) Smoking 7 23.3% 6 20%
b) Alcoholism 4 13.3% 1 3.33%
c) Betal chewing 19 63.3% 23 76.6%
7 Chemotherapy drugs
a) Cisplatin 8 26.66% 13 43.3%
b) Cyclophosphamide 7 23.3% 5 16.6%
c) Docetaxel 6 20% 4 13.3%
d) Vinblastine sulphate 9 30% 8 26.6%
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8 Stages of cancer
a) I 7 23.3% 2 6.6%
b) II 20 66.66% 9 30%
c) III 3 10% 19 63.3%
d) IV 0 0% 0 0%
9 Received chemotherapy
a) 1-5 times 11 36.66% 4 13.3%
b) 5-10 times 17 56.66% 5 16.6%
c) 10-15 times 2 6.66% 12 40%
d) Above – 15 times 0 0% 9 30%
10 What is the duration of illness?
a) Less than 1 yr 7 23.3% 2 6.6%
b) 1-4 yrs 21 70% 13 43.3%
c) 4-8 yrs 2 6.66% 11 36.6%
d) Above 8 yrs 0 0% 4 13.3%
11 Types of cancer
a) Thyroid cancer 10 33.33% 9 30%
b) Breast cancer 7 23.3% 5 16.6%
c) Cancer of cervix 9 30% 14 46.6%
d) Lung cancer 4 13.33% 2 6.6%
Fig. 3: Bar diagram showing the distribution of sample by age in years
The above diagram shows that in experimental group 20% of patients
are 18-29 years old, 30% of patients are 30-41 years old, 36.60% of patients are
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42-53 years old and 13.30% of patients are 54-65 years old. In control group
20% of patients are 18-29 years old, 26.60% of patients are 30-41 years old,
36.60% of patients are 42-53 years old and 16.60% of patients are 54-65 years
old.
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Fig. 4: Bar diagram showing the distribution of sample by sex
The  above  diagram  shows  that,  in  experimental  group  36.60%  of
patients are male and 63.30% of patients are female. In control group 30% of
patients are male and 70% of patients are female.
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Fig. 5: Cylindrical diagram showing the distribution of sample by current
occupational status
The  above  diagram  shows  that,  in  experimental  group  56.66%  of
patients are doing coolly job, 10% of patients are doing business, 16.60% of
patients are private employee and 16.60% of patients are Govt. employee. In
control group 60% of patients are doing coolly job, 10% of patients are doing
business,  16.60% patients  are private  employee and 13.30% of patients  are
Govt. Employee.
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Fig. 6: Pyramidal diagram showing the distribution of sample according
their personal habits.
The  above  diagram  shows  that,  in  experimental  group  23.30%  of
patients  have  the  habit  of  smoking,  13.30%  of  patients  have  the  habit  of
drinking  alcoholism,  63.30%  of  patients  have  the  habits  of  betal  chewing.
Whereas, in control group 20% of patients have the habit of smoking, 3.33% of
patients have the habit of drinking alcoholism and 76.60% of patients have the
habit of betal chewing.
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Fig. 7: Cylindrical diagram showing the distribution of sample by stages of
cancer
The  above  diagram  shows  that,  in  experimental  group  23.30%  of
patients are in I stage, 66.66% of patients are in II stage and 10% of patients are
in III stage. Whereas, in control group 6.60% of patients are in I stage, 30% of
patients are in II stage, 10% of patients are in III stage and 0% of patients are in
III stage of cancer.
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Fig. 8: Conical diagram showing the distribution of sample by types of
cancer
The  above  diagram  shows  that,  in  experimental  group  33.33%  of
patients have thyroid cancer, 23.30% of patients have Breast cancer, 30% of
patients  have  cancer  of  cervix  and  13.33%  of  patients  have  lung  cancer.
Whereas, in control groups 30% of patients have thyroid cancer,  16.60% of
patients have cancer of cervix and 6.60% of patients have lung cancer.
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SECTION – II
Table 2:  Day-by day scores of oral mucositis of control group
Day Minimumscore
Maximum
score Mean Mean % S.D
I 0 4 0 0 0
II 0 4 0.2 5 0.4068
III 0 4 0.3666 2.29 0.6296
IV 0 4 0.5666 14.165 0.6260
V 0 4 1 25 0.7877
VI 0 4 1.3333 33.3325 0.6607
VII 0 4 1.7 42.5 0.7943
VIII 0 4 2.1666 54.165 0.5085
IX 0 4 2.4 60 2.8342
X 0 4 2.6666 66.65 0.6608
Table 3:  Day-by day scores of oral mucositis of experimental group
Day Minimumscore
Maximum
score Mean Mean % S.D
I 0 4 0 0 0
II 0 4 0 0 0
III 0 4 0 0 0
IV 0 4 0 0 0
V 0 4 0 0 0
VI 0 4 0 0 0
VII 0 4 0.033 0.8325 0.1795
VIII 0 4 0.033 0.8325 0.1795
IX 0 4 0.0666 1.665 0.2451
X 0 4 0.1666 4.165 0.3865
Fig. 9: Line diagram showing the comparison of mean percentage score
obtained oral mucositis scale
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The above diagram shows that, in experimental group the mean score on
1 day to VII day 0, on the VII-day 0.033, on the VIII-day 0.033, on the IX day
0.06666 and on the X day 0.1666. In control group the mean score on the II day
0.2, on the III day 0.3666, on the IV day 0.5666, on the V day 1, on the VI day
1.3333, on the VII day 1.7 on the VIII day, on the IX day 2.4 and on the X day
2.666.
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Table 4: Grading of oral mucositis on the 10th day among control group
Grade Number of sample %
None (0) 0 0%
Mild (0-1) 1 3.3%
Moderate (2-3) 27 90%
Severe (4) 2 6.67%
Fig. 10: Cylindrical diagram shows the level of mucositis on control group
The above diagram shows that,  in control group on 10th day none of
patients  are  without  oral  mucositis,  3.30% of  patients  have developed mild
grade, of oral mucositis, 90% of patients have developed moderate grade of
oral  mucositis,  90%  of  patients  have  developed  moderate  grade  of  oral
mucositis and 6.67% of patients have developed severe grade of oral mucositis.
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Table 5: Grading of oral mucositis on the 10th day among 
Experimental group
Grade Number of sample %
None (0) 26 86.67%
Mild (0-1) 3 10%
Moderate (2-3) 1 3.33%
Severe (4) 0 0%
Fig. 11: Conical diagram shows the level of mucositis on 
Experimental group
The above diagram shows that, in experimental group on 10th day 10%
of patients have developed mild grade of oral mucositis and 3.33% of patients
have developed moderates grade of oral mucositis.
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SECTION - III
Table 6: Day – by – day comparison of grading of oral mucositis between
control group and experimental group
Day Group Mean MeanDifference S.D ‘t’ value Significance
I Experimental - - - -Control
II Experimental - - - -Control
III Experimental - - - -Control
IV Experimental - - -Control
V Experimental - - - -Control
VI Experimental - - -Control
VII
Experimental 0.033
1.667
0.575817
9
11.212345 SignificantControl 1.7
VIII
Experimental 0.033
2.1336
0.381308
5
3.3441685
8
SignificantControl 2.166
6
IX
Experimental 0.066
6 2.1
2.011611
2
4.4928805 SignificantControl 2.166
6
X
Experimental 0.166
6 2.4994
0.541312
6
17.887014 Significant
Control 2.666
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SECTION IV
Table 7: Association between grading of oral mucositis on 10th day of
control group and demographic variables
S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
Significance
No
Mucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
1. Age (in years)
χ2 =
8.743
Df=6
Not
Significant
P>0.05
a) 18-29 0 0 1 16.6
7
5 83.33 0 0
b) 30-41 0 0 0 0 8 100 0 0
c) 42-53 0 0 0 0 9 81.81 2 18.1
9
d) 54-65 0 0 0 0 5 100 0 0
2. Sex
a) Male 0 0 1 11.1
1
8 88.89 0 0 χ2 =
2.928
Df=2
Not
Significant
P>0.05b) Female 0 0 0 0 1
9
90.48 2 9.52
3. Occupation
a) Cooly 0 0 0 0 1
7
94.44 1 1.55 χ2 =
20.750
Df=6
Significant
P<0.05
b) Business man 0 0 0 0 3 100 0 0
c) Private 
employee
0 0 1 20 3 60 1 20
d) Govt. employee 0 0 0 0 4 100 0 0
4. Frequency of mouth wash
a) Once a day 0 0 0 0 7 100 0 0 χ2 =
4.726
Df=6
Not
Significant
P>0.05
b) Twice a day 0 0 1 11.1
1
8 88.88 0 0
c) Every time after
eating
0 0 0 0 1
2
85.71 2 14.2
8
d) Any specific 0 0 0 0 0 0 0 0
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S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
SignificanceNoMucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
5 Frequency of Brushing
a) Once a day 0 0 0 0 2
2
91.67 2 8.33 χ2 =
11.737
Df=3
Significant
P<0.05
b) Twice a day 0 0 0 0 5 83.33 0 0
c) Every time after
eating
0 0 0 0 0 0 0 0
d) Any specific 0 0 0 0 0 0 0 0
6 Personal habits
a) Smoking 0 0 1 16.6
6
5 83.33 0 0 χ2 =
4.753
Df=4
Not
Significant
P>0.05b) Alcoholism 0 0 0 0 1 100.0
0
0 0
c) Betal chewing 0 0 0 0 2
1
91.30 2 8.69
7 Chemotherapy drugs
a) Cisplatin 0 0 0 0 1
2
92.30 1 7.69
2
χ2 =
5.017
Df=6
Not
Significant
P>0.05b) 
Cyclophosphamide
0 0 0 0 4 80 1 20
c) Docetaxel 0 0 0 0 4 100 0 0
d) Vinblastine 
sulphate
0 0 1 12.5 7 87.5 0 0
8 Stages of cancer
a) I 0 0 1 50 1 50 0 0 χ2 =
30.946
Df=6
Significant
P<0.05b) II 0 0 0 0 9 100 0 0
c) III 0 0 0 0 1
7
89.48 2 10.5
2
d) IV 0 0 0 0 0 0 0 0
9 Received chemotherapy
a) 1-5 times 0 0 1 25 3 75 0 0 χ2 =
15.124
Df=6
Significant
P<0.05b) 5-10 times 0 0 0 0 5 100 0 0
c) 10-15 times 0 0 0 0 1
0
83.3 2 16.6
6
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d) Above 15 times 0 0 0 0 9 100 0 0
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S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
SignificanceNoMucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
10 What is the duration of illness?
a) Less then 1 yr 0 0 1 50 1 50 0 0 χ2 =
17.714
Df=6
Significant
P<0.05b) 1-4 yrs 0 0 0 0 1
3
100 0 0
c) 4-9 yrs 0 0 0 0 1
0
90.90 1 9.09
d) Above 8 yrs 0 0 0 0 3 75 1 25
11 Types of cancer
a) Thyroid cancer 0 0 1 11.1
1
8 88.88 0 0 χ2 =
4.726
Df=6
 Significant 
P<0.05
b) Breast cancer 0 0 0 0 5 100 0 0
c) Cancer of 
cervix
0 0 0 0 1
2
85.71 2 14.2
8
d) Lung cancer 0 0 0 0 2 100 0 0
The  above  table  shows  that  in  control  group  there  is  significant
relationship between prevention of oral mucositis and demographic variables
occupation,  frequency  of  brushing,  stages  of  cancer,  chemotherapy  and
duration of illness. There is no significant relationship between prevention of
oral  mucositis  and  demographic  variables  age,  sex,  mouth  wash,  personal
habits, chemotherapy drugs, and types of cancer.
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Fig. 12 : Cylindrical diagram showing the association between stages of
cancer and oral mucositis (Control group)
The  above  diagram shows  that,  in  control  group  there  is  significant
association between stages of cancer and level of oral mucositis.
Fig. 13 : Pyramidal diagram showing the association between
chemotherapy and oral mucositis (Control group)
The  above  diagram shows  that,  in  control  group  there  is  significant
association between chemotherapy and level of oral mucositis.
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Fig. 14 : Cylindrical diagram showing the association between duration of
illness and oral mucositis (Control group)
The  above  diagram shows  that,  in  control  group  there  is  significant
association between duration of illness and oral mucositis.
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Table 8 : Association between grading of oral mucositis on 10th day of
Experimental group and demographic variables
S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
Significance
No
Mucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
1. Age (in years)
χ2 =
7.285
Df=6
Not
Significant
P>0.05
a) 18-29 5 83.3 1 16.7 0 0 0 0
b) 30-41 8 88.9 1 11.1 0 0 0 0
c) 42-53 10 90.9 1 9.1 0 0 0 0
d) 54-65 3 75 0 0 1 25 0 0
2. Sex χ2 =
1.786
Df=2
Not
Significant
P>0.05
a) Male 9 81.8 2 18.2 0 0 0 0
b) Female 17 89.4
7
1 5.26 1 5.26 0 0
3. Occupation
χ2 =
2.343
Df=6
Not
Significant
P>0.05
a) Cooly 14 82.3
5
2 11.7
6
1 5.89 0 0
b) Business man 3 100 0 0 0 0 0 0
c) Private 
employee
5 100 0 0 0 0 0 0
d) Govt. employee 4 80 1 20 0 0 0 0
4. Frequency of mouth wash
χ2 =
29.239
Df=6
Significant
P>0.05
a) Once a day 0 0 3 75 1 25 0 0
b) Twice a day 4 100 0 0 0 0 0 0
c) Every time after
eating
22 91.7 0 0 0 0 0 0
d) Any specific 0 0 0 0 0 0 0 0
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S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
SignificanceNoMucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
5 Frequency of Brushing
χ2 =
4.259
Df=4
Not
Significant
P>0.05
a) Once a day 8 88.9 0 0 1 11.11 0 0
b) Twice a day 15 88.23 2 11.7
7
0 0 0 0
c) Every time after
eating
3 75 1 25 0 0 0 0
d) Any specific 0 0 0 0 0 0 0 0
6 Personal habits
χ2 =
2.114
Df=4
Not
Significant
P>0.05
a) Smoking 6 85.71 1 14.2
9
0 0 0 0
b) Alcoholism 3 75 1 25 0 0 0 0
c) Betal chewing 17 89.48 1 5.26 1 5.26 0 0
7 Chemotherapy drugs
χ2 =
5.474
Df=6
Not
Significant
P>0.05
a) Cisplatin 7 87.5 1 12.5 0 0 0 0
b) 
Cyclophosphamide
7 100 0 0 0 0 0 0
c) Docetaxel 4 66.6 1 16.7 1 16.7 0 0
d) Vinblastine 
sulphate
8 88.8 1 11.1 0 0 0 0
8 Stages of cancer χ2
23.772
Df=4
Significant
P<0.05
a) I 6 85.71 1 14.2
9
0 0 0 0
b) II 20 100 0 0 0 0 0 0
c) III 0 0 2 66.7 1 33.3 0 0
d) IV 0 0 0 0 0 0 0 0
9 Received chemotherapy χ2 =
19.362
Df=4
Significant
P<0.05
a) 1-5 times 10 90.91 1 9.09 0 0 0 0
b) 5-10 times 16 94.11 1 5.89 0 0 0 0
c) 10-15 times 0 0 1 50 1 50 0 0
d) Above 15 times 0 0 0 0 0 0 0 0
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S.
No.
Demographic
Variables
Grading of oral mucositis Chi-
Square
Value
SignificanceNoMucositis
Mild
Mucositis
Moderate
Mucositis
Severe
Mucositis
N % N % N % N %
10 What is the duration of illness? χ2 =
19.812
Df=4
Significant
P<0.05
a) Less than 1 yr 6 85.7 1 14.3 0 0 0 0
b) 1-4 yrs 20 95.23 1 4.77 0 0 0 0
c) 4-9 yrs 0 0 1 50 1 50 0 0
d) Above 8 yrs 0 0 0 0 0 0 0 0
11 Types of cancer
χ2 =
4.409
Df=4
Not
Significant
P>0.05
a) Thyroid cancer 9 90 1 10 0 0 0 0
b) Breast cancer 6 85.71 1 14.2
9
0 0 0 0
c) Cancer of 
cervix
8 88.8 0 0 1 11.2 0 0
d) Lung cancer 3 75 1 25 0 0 0 0
The above table shows that in experimental group there is significant
relationship between prevention of oral mucositis and demographic variables
frequency  of  mouth  wash,  stages  of  cancer,  chemotherapy  and  duration  of
illness.  There  is  no  significant  relationship  between  prevention  of  oral
mucositis  and  demographic  variables  age,  sex,  occupation,  frequency  of
brushing, personal habits, chemotherapy drugs, and types of cancer.
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Fig. 15 : Conical diagram showing the association between stages of cancer
and oral mucositis (Experimental group)
The  above  diagram  shows  that,  in  experimental  group  there  is
significant association between stages of cancer and level of oral mucositis.
Fig. 16 : Cylindrical diagram showing the association between
chemotherapy and oral mucositis (Experimental group)
The  above  diagram  shows  that,  in  experimental  group  there  is
significant association between chemotherapy and level of oral mucositis.
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Fig. 17 : Pyramidal diagram showing the association between duration  of
illness and oral mucositis (Experimental group)
The  above  diagram  shows  that,  in  experimental  group  there  is
significant association between duration of illness and level of oral mucositis.
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CHAPTER V
DISCUSSION, IMPLICATIONS AND CONCLUSION
This  chapter  deals  with  the  discussion  of  the  study with  appropriate
literature  review,  statistical  analysis  and  findings  of  the  study  based  on
objective  of  the  study.  The  aim  of  the  study  was  on  prevention  of  oral
mucositis  among  patients  receiving  chemotherapy  admitted  to  the  ECC
hospital, Thindal at Erode district. A quantitative approach was adopted for this
study and purposive sampling techniques were used to collect the samples. The
data was collected from 60 patients.
The  findings  of  the  study  have  been  discussed  with  reference  to  the
objectives. 
MAJOR FINDINGS OF THE STUDY:
1. The first objective of the study was to assess the degree of occurrence of
oral  mucositis  among  patients  receiving  chemotherapy  who  receive
normal saline mouth wash.
In experimental group after giving normal saline mouth wash. On 10th
day  one  subject  (3.33%)  had  developed  moderate  oral  mucositis,  and  one
subject (3.33%) had developed mild oral mucositis.
2. The second objective  was  to  assess  the  degree  of  occurrence of  oral
mucositis  among patients receiving chemotherapy who do not receive
normal saline mouth wash.
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On  10th day,  2  (6.67%)  of  the  samples  had  developed  severe  oral
mucositis, 27 (90%) of the samples had developed moderate oral mucositis and
one subject (3.3%) had developed mild oral mucositis in the control group
3. The third objective was to evaluate the effectiveness of normal saline
mouth wash by comparing the occurrence of oral mucositis among the
patients of experimental group and control group.
The mean difference between experimental and control group on 7th day
1.667, 8th day 2.1336, 9th day 2.1 and 10th day 2.4994.
Calculated  the’t’  value  on  7th day,  11.80035219  on  8th day  t  value
3.78760275,  on  9th day  t  value  4.526250023,  and  on  10th day  t  value
25.54773056.
Hajizadeh, 2009, conducted study alloporinol, Chamomile and normal
saline mouthwashes for prevention of chemotherapy induced mucositis in that
chamomile (group 2) or normal saline (group 3). ANOVA and 2 tests have
been used for data analysing.  Results,  Significant differences were obtained
between allopurinol, chamomile and normal saline groups in scores of severity
of mucositis (p=0.017), mucositis pain (p=0.027) and persistence of mucositis.
No  significant  differences  noted  among  the  mean  stomatitis  (p=0.59)  and
mucositis  pain  (0.071)  severity  scores  between  group  1  and  group  2.
Conclusions.  These  findings  indicate  equal  efficacy  of  allopurinol  and
chamomile  in  prevention  of  chemotherapy-induced  mucositis  compared  to
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normal  saline  control  group.  Considering  the  cost  and easy  accessibility  of
normal saline and potential therapeutic applicability in reduction of the severity
of chemotherapy-induced, it's implied.
Since there is significant difference between experimental and control
group in the occurrence of oral mucositis, hence H1 is accepted, (normal saline
mouth wash is effective in preventing the occurrence of oral mucositis among
patients receiving chemotherapy).
4.   The fourth objective was to find out the association between the occurrence
of oral mucositis among patients and their selected demographic variables:
In  control  group  the  chi-square  value  for  the  occupation  χ2=20.750,
frequency  of  brushing  χ2 =11.737,  stages  of  cancer  χ2  =30.646,  received
chemotherapy χ2 =15.124, and duration of illness χ2 =17.716.
Hence, there is significant association between the occurrence of oral
mucositis  and  selected  demographic  variables  as  occupation,  frequency  of
brushing, stages of cancer, received chemotherapy and duration of illness.
In experimental group the chi square value of the frequency of mouth
wash  χ2  =19.551, stages of cancer  χ2  =23.772, chemotherapy x2=19.362, and
duration of illness χ2=19.812.
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Hence, there is significant association between the occurrence of oral 
mucositis and selected demographic variables as the frequency of mouth wash, 
stages of cancer,    chemotherapy and duration of illness.
IMPLICATION OF THE STUDY:
A research finding is not just to prove the hypothesis framed, it is to
implicate the practice for the well being of human. The researcher would like
to implicate the research findings into various aspects such as nursing practice,
nursing  education,  nursing  administration  and  nursing  research  for  the
upcoming level of professionalism.
Nursing practice:
"Practice makes man perfect". The positive result of the current study
can be practiced in respect to prevent oral mucositis by using normal saline
mouth wash as a routine nursing care to those clients receiving chemotherapy.
It  can be made as mandatory for all  cancer units to be followed as a basic
routine part. It is a prime responsibility for every nurse to preserve the client
self  image  by  their  effort  which  is  a  basic  foundation  for  the  client-nurse
relationship.
Nursing education:
"Education brings a change in the behavior of one".
The nursing curriculum entitles the personal hygiene which is a basic
need to be satisfied. According to the Maslow hierarchy needs the personal
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hygiene is a primary need which is to be satisfied without neglection. It is an
important  responsibility  of  every  nurse  to  satisfy  the  need  expected  to  be
satisfied in the clients. The cancer patients need to maintain the oral mucosal
integrity which is to be satisfied and understand by all the nurses.
Nursing administration:
A protocol can be prepared to use the normal saline mouth wash as a
part of care to those under chemotherapy medication, which essentially needs a
nursing administrator to organize the continuing nursing education programme
to enforce this apart in nursing care.
Nursing research:
It is very important for nursing research to have a detailed study about
certain measures which prevent the clients from oral mucositis, through those
measures like normal saline mouth wash are of with low cost shows high effect.
The emerging trend of evidence based nursing is a key which can be triggered
by a broad sensation of further researcher.
RECOMMENDATION:
¾ A comparative study can be performed to evaluate the effectiveness of
different  oral  mouth  wash,  providone  iodine,  chlorhexidine,  normal
saline.
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¾ A similar study can be replicated with a control group on large sample.
¾ Same study can be repeated on patient taking radiation therapy for head 
and neck cancer.
CONCLUSION:
"A perfect stitch makes a perfect body". The research findings of the
present study have proved that the normal saline mouth wash is effective in
preventing the client from the occurrence of oral mucositis among those who
are receiving chemotherapy. Thus it is getting from the verb that, "prevention is
better than cure", the nurse who is taking care of a client can prevent their
clients from oral mucositis thus preserves the client self image and gives way to
the client to be esteemed one.
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ANNEXURE – VI
SECTION – I
DEMOGRAPHIC PROFORMA
Sample No :
1) Age (in years)
a) 18-29 [     ]
b) 30-41 [     ]
c) 42-53 [     ]
d) 54-65 [     ]
2) Sex
a. Male [     ]
b. Female [     ]
3) Current occupation status :
a. Cooly [     ]
b. Business man [     ]
c. Private employee [     ]
d. Government employee [     ]
4) Frequency of mouth wash
a. Once a day [     ]
b. Twice a day [     ]
c. Every time after eating [     ]
d. Any other schedule (specify) [     ]
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5) Frequency of brushing
a. Once a day [     ]
b. Twice a day [     ]
c. Every time after eating [     ]
d. Any other schedule (specify) [     ]
6) Personal habits
a. Smoking [     ]
b. Alcoholism [     ]
c. Betal chewing [     ]
7) Chemotherapy drugs used
a. Cisplatine [     ]
b. Cyclophosphasmide [     ]
c. Docetaxel [     ]
d. Vinblastine sulphate [     ]
8) At which stage of cancer the patient is present
a. Ist [     ]
b. 2nd [     ]
c. 3rd [     ]
d. 4th [     ]
9) How many times you have received chemotheraphy before
a. 1-5 [     ]
b. 5-10 [     ]
c. 10-15 [     ]
d. Above 15 [     ]
99
10) What is the duration of illness?
a. less than 1 year [     ]
b. 1-4 years [     ]
c. 4-8 years [     ]
d. Above 8 years [     ]
11) Types of cancer
a. Throid cancer [     ]
b. Breast cancer [     ]
c. Cancer of cervix [     ]
d. Lung cancer [     ]
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Tool- II W.H.O ORAL MUCOSITIS ASSESSMENT SCALE
The researcher will be using the following scale to assess the grade of
mucositis in patients receiving chemotherapy after thoroughly inspecting their
oral cavity on the 10th day of their chemotherapy cycle.
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
None Soreness + 
Erythema
Erythema, 
ulcers, can 
eat solid food
Ulcers with 
extensive 
erthema, liquid 
diet only
No possible 
alimentation
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gFjp -1
r\fk; rhh;e;j Ratptuk;:
1. taJ (tUl';fspy;)
m. 18-29 [      ]
M. 30-41 [      ]
,. 42-53 [      ]
<. 54-65 [      ]
2. ghypdk;
m. Mz; [      ]
M. bgz; [      ]
3. jw;nghija bjhHpy; epiy
m. Typ [      ]
M. tpahghhp [      ]
,. jdpahh; bjhHpyhsp [      ]
<. muR CHpah; [      ]
4. xU ehisf;F vj;jid Kiw c';fs; thia Rj;jg;gLj;JtPh;fs;>
m. xU jlit [      ]
M. ,uz;L jlit [      ]
,. rhg;gpl;l gpwF [      ]
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<. ntW VjhtJ gHf;f Kiw (tpsf;ft[k;) [      ]
5. xU ehisf;F vj;jid Kiw gy; Jyf;FtPh;fs;>
m. xU jlit [      ]
M. ,uz;L jlit [      ]
,. rhg;gpl;l gpwF [      ]
<. ntW VjhtJ gHf;f Kiw (tpsf;ft[k;) [      ]
6. jdp kdpj gHf;f tHf;f';fs;
m. g[ifg;gHf;fk; [      ]
M. kJg;gHf;fk; [      ]
,. btw;wpiyghf;F [      ]
7. QPnkhbjugp kUe;Jfs;
m. rp!;gpyhl;od; [      ]
M. irf;nshgh!;ikL [      ]
,. lhf;lb$y; [      ]
<. tpd;gpsh!;od; ry;ngl; [      ]
8. j';fSf;F g[w;W neha; ve;j epiyapy; cs;sJ.
m. Kjy; [      ]
M. ,uz;lhtJ [      ]
,. \d;whtJ [      ]
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<. ehd;fhtJ [      ]
9. ,jw;F Kd;dhy; vj;jid Kiw QPnkhbjugp vLj;Js;sPh;fs;>
m. 1-5 [      ]
M. 5-10 [      ]
,. 10-15 [      ]
<. 15 Kiwf;F nky; [      ]
10. c';fSila nehapd; epiy vg;bghGJ fz;lwpag;gl;lJ>
m. 1 tUlj;jpw;Fs; [      ]
M. 1-4 tUl';fs; [      ]
,. 4-8 tUl';fs; [      ]
<. 8 tUlj;jpw;F nky; [      ]
11. j';fSf;F ve;j g[w;Wneha; cs;sJ.
m. ijuha;L g[w;Wneha; [      ]
M. khh;gf g[w;Wneha; [      ]
,. fh;g;gg;ig g[w;Wneha; [      ]
<. EiuaPuy; g[w;Wneha; [      ]
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gFjp -2
tha;g;g[z;iz kjpg;gpLjy;:
gphpt[ - 0 gphpt[ - 1 gphpt[ -2 gphpt[ - 4 gphpt[ - 4
rpwpJk; ,y;iy rpwpJ 
Rfkpd;ik
tha;g;g[z; ,
Ue;j 
nghjpYk; 
jplkhd 
cztpid 
cl;bfhs;s 
KofpwJ.
tha;g;g[z; 
mjpfkhf 
,Ug;gjpdhy; 
jplkhd czt[g; 
bghUis 
cl;bfhs;s 
,aytpy;iy.
tha;g;g[z; kpf
mjpfkhf 
,Ug;gjpdhy; 
jput cztpid 
cl;bfhs;s 
,aytpy;iy.
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108
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